Department of General Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2426321. doi: 10.1080/21645515.2024.2426321. Epub 2024 Nov 14.
Although IL-22 has been extensively studied, a comprehensive and systematic bibliometric analysis has not yet been conducted on it. This article reviews the research progress of IL-22 using bibliometric methods. On May 20, 2024, publications related to IL-22 were identified and selected from the Web of Science Core Collection (WoSCC) database. CiteSpace and VOSviewer are beneficial for IL-22 bibliometric and knowledge graph analysis. From January 1, 2014 to December 31, 2023, 25134 authors from 4206 institutions in 106 countries published 3943 articles on IL-22 research in 940 academic journals. During this period, the number of articles steadily increased. The United States and China are the main contributors to this research field, with the most active institutions being the Medical Research Institute (INSERM) led by De la Sante et al. and the University of California system. The most prolific journal is Frontiers of Immunology, and it is also the journal with the most citations. Guttman Yassky, E. has published the most articles, and Guttman Yassky, E. is also the most frequently cited. The main areas of these publications are immunology and cell biology. After analysis, the high-frequency keywords of IL-22 research involve molecular biology (IL-17) and immune response (T cells) Th17 cells and diseases (autoimmune diseases, cancer). Among them, the involvement of interleukin-22 in microbial populations and cancer cell spread has strong research potential and is currently a hot research topic. Since 2014, IL-22 has received significant attention in scientific research as a key immune regulatory factor. China is at the forefront of research in this field, followed closely by the United States. At present, breakthrough progress is being made in the research of immunotherapy, and in-depth study of IL-22 and its signal transduction mechanisms is crucial for understanding its biological functions. Meanwhile, exploring new possibilities for IL-22 as a therapeutic target will help develop more effective treatment strategies. This study can provide scholars with research directions related to IL-22.
虽然白细胞介素-22(IL-22)已经被广泛研究,但尚未对其进行全面系统的文献计量分析。本文采用文献计量学方法综述了 IL-22 的研究进展。于 2024 年 5 月 20 日,从 Web of Science 核心合集(WoSCC)数据库中确定并选取了与 IL-22 相关的出版物。CiteSpace 和 VOSviewer 有利于 IL-22 的文献计量和知识图谱分析。从 2014 年 1 月 1 日至 2023 年 12 月 31 日,来自 106 个国家的 4206 个机构的 25134 位作者在 940 种学术期刊上发表了 3943 篇关于 IL-22 研究的文章。在此期间,文章数量稳步增加。美国和中国是该研究领域的主要贡献者,最活跃的机构是由 De la Sante 等人领导的法国国家健康与医学研究院(INSERM)和加利福尼亚大学系统。发文量最多的期刊是《免疫学前沿》Frontiers of Immunology,也是被引频次最高的期刊。这些出版物的主要领域是免疫学和细胞生物学。分析后发现,IL-22 研究的高频关键词涉及分子生物学(IL-17)和免疫反应(T 细胞)、Th17 细胞和疾病(自身免疫性疾病、癌症)。其中,白细胞介素-22 参与微生物群和癌细胞扩散具有很强的研究潜力,是目前的热门研究课题。自 2014 年以来,白细胞介素-22 作为关键免疫调节因子在科学研究中受到高度关注。中国在该领域的研究处于领先地位,其次是美国。目前,免疫疗法的研究取得了突破性进展,深入研究白细胞介素-22 及其信号转导机制对于理解其生物学功能至关重要。同时,探索白细胞介素-22 作为治疗靶点的新可能性将有助于开发更有效的治疗策略。本研究可为学者提供与白细胞介素-22 相关的研究方向。